IOP lowered with trab and combination trab

Article

IOP is successfully reduced with both trabeculectomy and combined trabeculotomy-trabeculectomy with mitomycin C in children with glaucoma.

IOP is successfully reduced with both trabeculectomy and combined trabeculotomy-trabeculectomy with mitomycin C in children with glaucoma.

The retrospective, comparative study, led by Dr Peter A. Netland, Department of Ophthalmology (SDL), University of North Carolina, Chapel Hill, North Carolina, USA, included 40 eyes of 33 glaucoma patients.

Trabeculectomy was performed on 17 eyes (Group 1) and 23 eyes underwent combined trabeculotomy-trabeculectomy (Group 2), with mitomycin C administered to all patients. Successful surgery was defined if IOP was 21 mmHg or less and greater than 5 mmHg without additional surgery.

No significant difference in mean IOP reduction was found between the groups during follow-up. There was a higher success rate after surgery in group 2, compared to group 1. There were five treatment failures in group 1 and two in group 2. The failures were caused increased IOP or hypotony and there were no complications observed.

Both procedures are equally effective in lowering average IOP in children with glaucoma, but combined trabeculotomy-trabeculectomy was linked to greater long-term successful outcomes.

More detailed information may be found at the Journal of Paediatric Ophthalmology and Strabismus, click here

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.